Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Japanese (NIKKEI) Biotech Industry Analysis

UpdatedDec 15, 2025
DataAggregated Company Financials
Companies34
  • 7D0.7%
  • 3M-17.1%
  • 1Y-11.7%
  • YTDn/a

The Biotech is pretty flat in the last 7 days, but PeptiDream has stood out, gaining 7.5%. As for the longer term, the industry has declined 12% in the last year. Looking forward, earnings are forecast to grow by 33% annually.

Industry Valuation and Performance

Has the Japanese Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Tue, 16 Dec 2025JP¥991.4bJP¥197.4b-JP¥71,614,409,000.0037x-13.8x5x
Thu, 13 Nov 2025JP¥1.1tJP¥197.7b-JP¥63,181,000,000.0064.1x-17.3x5.5x
Sat, 11 Oct 2025JP¥1.2tJP¥197.7b-JP¥65,794,561,000.0063.2x-18.5x6.2x
Mon, 08 Sep 2025JP¥1.2tJP¥193.5b-JP¥68,135,862,000.00123.8x-17.3x6.1x
Wed, 06 Aug 2025JP¥1.2tJP¥218.1b-JP¥46,563,403,000.00111.2x-25.5x5.4x
Fri, 04 Jul 2025JP¥1.1tJP¥218.2b-JP¥43,672,020,000.0096.2x-24.2x4.8x
Sun, 01 Jun 2025JP¥1.2tJP¥214.8b-JP¥40,596,253,000.0015.3x-29.6x5.6x
Tue, 29 Apr 2025JP¥1.0tJP¥207.8b-JP¥39,029,205,000.0014.6x-26.5x5x
Thu, 27 Mar 2025JP¥1.0tJP¥207.8b-JP¥39,285,917,000.0015.9x-26.6x5x
Sat, 22 Feb 2025JP¥1.1tJP¥207.4b-JP¥38,725,293,000.0015.6x-27.7x5.2x
Mon, 20 Jan 2025JP¥995.1bJP¥207.3b-JP¥13,514,452,000.0020.1x-73.6x4.8x
Wed, 18 Dec 2024JP¥1.1tJP¥206.4b-JP¥9,855,899,000.0021.9x-108.4x5.2x
Fri, 15 Nov 2024JP¥1.1tJP¥215.7b-JP¥6,576,514,000.0022.8x-167.7x5.1x
Sun, 13 Oct 2024JP¥1.1tJP¥214.3b-JP¥2,078,229,000.0021.1x-526x5.1x
Tue, 10 Sep 2024JP¥1.0tJP¥210.1b-JP¥469,229,000.0015.7x-2203.5x4.9x
Thu, 08 Aug 2024JP¥962.8bJP¥187.5b-JP¥16,096,875,000.0053.7x-59.8x5.1x
Sat, 06 Jul 2024JP¥1.0tJP¥187.7b-JP¥15,773,284,000.0091.4x-64.3x5.4x
Mon, 03 Jun 2024JP¥807.8bJP¥195.7b-JP¥14,113,047,000.0093.9x-57.2x4.1x
Wed, 01 May 2024JP¥806.9bJP¥198.9b-JP¥14,917,877,000.0046.8x-54.1x4.1x
Fri, 29 Mar 2024JP¥752.5bJP¥194.2b-JP¥15,458,035,000.0060.3x-48.7x3.9x
Sun, 25 Feb 2024JP¥807.8bJP¥196.2b-JP¥18,778,997,000.0065.3x-43x4.1x
Tue, 23 Jan 2024JP¥776.5bJP¥222.3b-JP¥12,604,827,000.0017.1x-61.6x3.5x
Thu, 21 Dec 2023JP¥762.8bJP¥224.2b-JP¥12,970,409,000.0017x-58.8x3.4x
Sat, 18 Nov 2023JP¥774.1bJP¥220.1b-JP¥9,607,487,000.0016.9x-80.6x3.5x
Mon, 16 Oct 2023JP¥787.0bJP¥223.0b-JP¥14,478,735,000.0022.7x-54.4x3.5x
Wed, 13 Sep 2023JP¥881.8bJP¥225.3b-JP¥17,478,085,000.0027.1x-50.4x3.9x
Fri, 11 Aug 2023JP¥875.3bJP¥218.7b-JP¥22,219,491,000.0051x-39.4x4x
Sun, 09 Jul 2023JP¥939.3bJP¥223.0b-JP¥19,224,669,000.0056.9x-48.9x4.2x
Tue, 06 Jun 2023JP¥976.6bJP¥218.4b-JP¥25,405,670,000.0038.9x-38.4x4.5x
Thu, 04 May 2023JP¥892.4bJP¥218.2b-JP¥20,061,938,000.0020.8x-44.5x4.1x
Sat, 01 Apr 2023JP¥914.1bJP¥218.3b-JP¥21,583,164,000.0021.3x-42.4x4.2x
Mon, 27 Feb 2023JP¥935.9bJP¥216.2b-JP¥18,991,580,000.0021x-49.3x4.3x
Wed, 25 Jan 2023JP¥946.7bJP¥186.8b-JP¥24,722,604,000.0040.2x-38.3x5.1x
Fri, 23 Dec 2022JP¥859.4bJP¥186.8b-JP¥24,723,433,000.0039.4x-34.8x4.6x
Price to Earnings Ratio

-34.8x


Total Market Cap: JP¥859.4bTotal Earnings: -JP¥24,723,433,000.00Total Revenue: JP¥186.8bTotal Market Cap vs Earnings and Revenue0%0%0%
Japanese Biotech Industry Price to Earnings3Y Average -118.2x202320242025
Current Industry PE
  • Investors are relatively neutral on the Japanese Biotechnology industry at the moment, indicating that they anticipate long term growth rates to remain steady.
  • The industry is trading close to its 3-year average PS ratio of 4.7x.
Past Earnings Growth
  • The earnings for companies in the Biotechnology industry have deteriorated over the last three years.
  • Meanwhile revenues have remained mostly flat.
  • This means that although sales have remained flat, either the cost of doing business or the level of investment back into businesses has increased, which has caused losses to expand.

Industry Comparison

How does Japanese Biotech compare with similar industries?

JP Market1.69%
Healthcare0.78%
Biotech0.67%
Biotech0.67%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
4587 PeptiDreamJP¥1.74k7.5%
+JP¥15.6b		-32.7%PS12.5x
2160 GNI GroupJP¥2.48k9.6%
+JP¥12.1b		-18.8%PS5.3x
219A HeartseedJP¥2.13k5.9%
+JP¥2.7b		-8.9%PE93.6x
7777 3-D MatrixJP¥353.004.7%
+JP¥1.8b		175.8%PS5.3x
4974 Takara BioJP¥787.001.4%
+JP¥1.3b		-22.5%PS2.2x

Latest News

2929
JP¥660.00
Pharma Foods International
7D
-11.2%
1Y
-27.4%
4587
JP¥1,737.50
PeptiDream
7D
7.5%
1Y
-32.7%
219A
JP¥2,133.00
Heartseed
7D
5.9%
1Y
-8.9%
7776
JP¥248.00
CellSeed
7D
-8.1%
1Y
-44.6%
4593
JP¥312.00
Healios K.K
7D
-25.0%
1Y
72.4%
4893
JP¥147.00
Noile-Immune Biotech
7D
-8.1%
1Y
-12.5%
4588
JP¥940.00
Oncolys BioPharma
7D
-5.7%
1Y
48.5%
4564
JP¥21.00
OncoTherapy Science
7D
5.0%
1Y
-27.6%
2342
JP¥247.00
Transgenic Group
7D
-32.0%
1Y
32.1%

Why Investors Shouldn't Be Surprised By Transgenic Group Inc.'s (TSE:2342) Low P/S

Nov 19
Why Investors Shouldn't Be Surprised By Transgenic Group Inc.'s (TSE:2342) Low P/S
2160
JP¥2,480.00
GNI Group
7D
9.6%
1Y
-18.8%
7777
JP¥353.00
3-D Matrix
7D
4.7%
1Y
175.8%

3-D Matrix, Ltd.'s (TSE:7777) Share Price Boosted 27% But Its Business Prospects Need A Lift Too

Nov 13
3-D Matrix, Ltd.'s (TSE:7777) Share Price Boosted 27% But Its Business Prospects Need A Lift Too
4974
JP¥787.00
Takara Bio
7D
1.4%
1Y
-22.5%
4592
JP¥1,665.00
SanBio
7D
-3.5%
1Y
84.4%
7774
JP¥471.00
Japan Tissue Engineering
7D
-3.5%
1Y
-1.5%
4598
JP¥563.00
Delta-Fly Pharma
7D
12.4%
1Y
-20.3%
4894
JP¥6,120.00
Cuorips
7D
0.7%
1Y
32.3%

Companies Like Cuorips (TSE:4894) Can Afford To Invest In Growth

Aug 17
Companies Like Cuorips (TSE:4894) Can Afford To Invest In Growth